Thank you for that.
I'll follow up on my colleague MP Noormohamed's question, Dr. Hamelin. Once Health Canada has approved in terms of the safety and effectiveness of the particular product, it seems, and we've certainly heard, that it's a duplicative effort on the part of provinces to a certain extent. They obviously have the issue of the cost and price of a particular product, perhaps, for their own jurisdiction.
Could you elaborate? I know you committed to sending written information, but could you tell us about how you could see streamlining that process?